Rancho Santa Fe Bio, Inc ("RSF Bio") is a clinical-stage, cardiovascular therapeutics platform company, based in San Diego, California.

RSF Bio is a clinical stage cardiovascular therapeutics platform company based in San Diego, California. Below is a description of our leadership team, scientific advisory board, and board …

Ataciguat has undergone extensive pre-clinical and clinical development for treatment of the progression of CAVS. The drug and its application in CAVS is now licensed to RSF Bio for …

Ataciguat, a nitric oxide-independent soluble guanylate cyclase activator, is being developed by RSF Bio for the treatment of moderate CAVS.

Please contact our RSF Bio team through the form, email, or number . provided below.

RSF Bio is interested in speaking with potential partners to license, develop, fund, and commercialize its technology and products on a country-by-country, or worldwide, basis.

We are looking to expand our product platform by exploring the development of additional indications (including orphan indications), developing a biomarker to be able to identify earlier …

Randy Berholtz, MBA/JD/M.Litt, is the Chairman of the Board and the Chief Executive Officer of the Company. He has over 20 years’ experience serving on the executive teams of biotech …

Rancho Santa Fe Bio, Inc. Company Profile

RSF Bio Press Release 6/17/21 (pdf) Download For questions regarding press releases, please feel free to contact the Rancho Santa Fe Bio team. Contact Our Team